Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P61278 (
somatostatin
)
22,083
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In a double-blind, placebo-controlled study, the central nervous system effects of an ACTH4-9 analog, Org2766 (40 mg/day), in Alzheimer's disease were assessed by measuring cerebrospinal fluid parameters during 6 months' treatment.
Somatostatin
-like immunoreactivity and
cholinesterase
activity, which are known to be reduced in cerebrospinal fluid of Alzheimer patients compared with controls, did not change during treatment. As a marker of noradrenergic and dopaminergic systems, we measured dopamine-beta-hydroxylase and homovanillic acid, but both levels were static. These results suggest that Org2766 did not interact with the transmitter systems, which are thought to be disturbed in Alzheimer's disease.
...
PMID:The effect of ACTH4-9 analog (Org2766) on some cerebrospinal fluid parameters in patients with Alzheimer's disease. 299 89
Somatostatin
-like immunoreactivity (SLI) and
acetylcholinesterase
(AchE) activities were measured in the cerebrospinal fluid of 25 patients with senile dementia of the Alzheimer type (SDAT). Both SLI levels and AchE activities were reduced in the CSF of SDAT patients. The SLI levels and AchE activities were not correlated with the duration and the dementia score. However, in two patients the CSF SLI concentration was in agreement with the SLI levels in the frontal cortex obtained by biopsy. Our findings suggest that CSF SLI may be a good index of cortical SLI activities.
...
PMID:Somatostatin-like immunoreactivity and acetylcholinesterase activities in cerebrospinal fluid of patients with Alzheimer disease and senile dementia of the Alzheimer type. 351 22
We have previously used organotypic cultures to study mechanisms regulating phenotypic expression of neurotransmitter characters in the brain. Our previous work indicated that nerve growth factor (NGF) specifically increased the activity of choline acetyltransferase (CAT) in striatal cholinergic interneurons. In the present study we examined the effect of NGF on neurons of fetal rat basal forebrain-medial septal area (BF-MS) maintained in organotypic culture. Treatment with 200 biological units/ml of NGF resulted in a 3- to 6-fold increase in the specific activity of CAT. This effect was specifically blocked by anti-NGF antiserum, whereas treatment with antiserum alone did not alter the cholinergic enzyme. NGF also elicited a marked increase in CAT staining intensity, using a monoclonal antibody directed against the enzyme. Further, the number of CAT-positive neurons appeared to increase in the NGF-treated cultures. Exposure to NGF also increased the activity of another cholinergic marker, the catabolic enzyme,
acetylcholinesterase
. The effect of NGF appeared to be highly selective, since substance P and
somatostatin
levels were unchanged by NGF treatment.
...
PMID:Nerve growth factor selectively increases cholinergic markers but not neuropeptides in rat basal forebrain in culture. 360 70
Autonomic innervation of the pancreas of the camel has been studied using histochemical techniques for the demonstration of adrenergic and cholinergic (
acetylcholinesterase
-positive) nerves. Both extrinsic and intrinsic innervation of the pancreas were found. Distinct peri-acinar, perivascular, peri-insular and periductal plexuses were found as well as both adrenergic and cholinergic ganglia. The role of the autonomic nerves in the synthesis and release of insulin, glucagon and
somatostatin
is discussed.
...
PMID:A histochemical study on the innervation of the pancreas of the one-humped camel (Camelus dromedarius). 365 46
Both Alzheimer's disease and senile dementia of the Alzheimer type (AD/SDAT) are progressive dementias characterized neuropathologically by the presence in the cerebral cortex of numerous neurofibrillary tangles and neuritic plaques. We use the abbreviation AD/SDAT to denote all such cases, irrespective of age of onset. Studies of neurotransmitter-related parameters in autopsied brain tissues from patients with AD/SDAT have, to date, been confined to five putative transmitter systems. Acetycholine-releasing neurones seem to be most markedly and consistently affected, as judged by the extensive reductions in choline acetyltransferase (ChAT) and
acetylcholinesterase
activities that have been reported. Despite numerous studies, there is no consistent evidence for the involvement of neurones releasing dopamine, noradrenaline, serotonin, or gamma-aminobutyric acid in AD/SDAT, nor for loss of muscarinic cholinergic receptors. Thus, the involvement of cholinergic neurones in AD/SDAT seems to be specific. However, the possible involvement of neurones using other chemicals as transmitters has yet to be explored. The recent recognition of the existence of so-called 'peptidergic neurones' in the mammalian brain (for review see ref. 8) and the availability of radioimmunoassay (RIA) techniques for studying these peptides, have led us to begin a systematic investigation of neuropeptides in autopsied brain tissue from cases of AD/SDAT, and from neurologically normal individuals. We report here results obtained with a RIA for
somatostatin
, showing that
somatostatin
-like immunoreactivity in the cerebral cortex is reduced in tissue from AD/SDAT patients.
...
PMID:Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. 610 62
The distributions of putative cholinergic and somatostatinergic amacrine cells of the chicken retina were compared. Acetylcholinesterase-positive amacrine cell bodies were concentrated at the border between the inner nuclear and plexiform layers. Similar amacrine cell bodies were detected in a displaced position in the ganglion cell layer. Both populations had dendrites joining the 4 bands of
acetylcholinesterase
activity in the inner plexiform layer. The cell bodies of
somatostatin
-immunoreactive amacrine cells were distinct from the intensely
acetylcholinesterase
-positive cell bodies. The immunoreactive terminal bands did not overlap the
acetylcholinesterase
-positive bands, except in the inner parts of the inner plexiform layer.
...
PMID:Discrete distributions of putative cholinergic and somatostatinergic amacrine cell dendrites in chicken retina. 612 Apr 88
Striatal neurons containing acetylcholine and
somatostatin
were examined using a pharmacohistochemical procedure for
acetylcholinesterase
and NADPH-diaphorase histochemistry respectively. The use of these two histochemical procedures allowed both cholinergic and
somatostatin
cells to be visualized simultaneously in single sections of the striatum. The results indicate that
somatostatin
and acetylcholine are contained in separate populations of striatal neurons and illustrate the utility of simple histochemical procedures to visualize biochemically defined neurons.
...
PMID:Histochemical demonstration of separate populations of somatostatin and cholinergic neurons in the rat striatum. 613 60
Cultures derived from rat cerebral hemispheres were sequentially stained for
acetylcholinesterase
activity and for either
somatostatin
-like immunoreactivity or cholecystokinin-like immunoreactivity.
Somatostatin
-like immunoreactivity was found to coexist with
acetylcholinesterase
activity in individual neurons of several morphological subtypes, but cholecystokinin-like immunoreactivity and acetycholinesterase activity were never seen in the same neurons. These findings suggest a specific anatomical association, perhaps even an overlap, of the cholinergic and somatostatinergic systems in the mammalian cerebrum, and indicate that the combined deficiencies of
somatostatin
and cholinergic markers in Alzheimer's dementia and senile dementia of the Alzheimer type may be of pathophysiological importance.
...
PMID:Coexistence of acetylcholinesterase and somatostatin-immunoreactivity in neurons cultured from rat cerebrum. 614 Jul 57
The distribution of
somatostatin
in the rat spinal cord was studied immunohistochemically with particular reference to the localization in the caudal centers that innervate the pelvic organs. For detailed studies of the laminar distribution of
somatostatin
the combination of immunohistochemistry and
acetylcholinesterase
enzyme histochemistry was employed. Deafferentation experiments were carried out to shed light on the origin of the
somatostatin
-containing axons. These experiments showed that the bulk of the spinal
somatostatin
has a spinal origin. The structures showing
somatostatin
immunoreactivity formed a distinct and detailed pattern. The marginal layer and particularly the substantia gelatinosa contained a dense immunoreactivity in terminallike structures. Such structures were also found in the reticular nucleus, along the medial border of the dorsal horn, and in the nucleus of the dorsolateral funiculus. In all of these regions
somatostatin
-positive cell bodies were also observed. In the intermediate gray matter stained terminals were present around the central canal in a varying number. The most prominent stainability was found in the lumbosacral transition zone. Many terminals were also observed in the sacral parasympathetic intermediolateral nucleus. In contrast, very few appeared in the sympathetic nuclei. Immunoreactive somata were present in the surroundings of the central canal at all levels. Moreover, positive neurons were found in the intermediolateral nucleus of the sacral cord. By combined retrograde tracing and immunohistochemistry the existence of
somatostatin
-containing parasympathetic visceromotoneurons was ascertained. Corresponding to this,
somatostatin
-positive terminals were seen in the major pelvic ganglion. The ventral horn generally contained few terminals, and the density was particularly low in the motoneuron neuropil. However, a dense
somatostatin
network was found in the sixth lumbar segment in relation to the neurons in Onuf's nucleus X complex, the nucleus that innervates the small pelvic muscles including the striated sphincters. It is concluded that
somatostatin
, besides being involved in the processing of sensory input, serves an important motor task, that of taking part in the complex control of the pelvic organs and their associated striated muscles.
...
PMID:Somatostatin in the caudal spinal cord: an immunohistochemical study of the spinal centers involved in the innervation of pelvic organs. 614 9
Cholinesterase (ChE) activity and
somatostatin
-like immunoreactivity (SLI) of the cerebrospinal fluid were determined for 59 patients with dementia of the Alzheimer type (AD/SDAT) and for 19 age-matched control patients with no signs of dementia. Both ChE activities and SLI concentrations of cerebrospinal fluid were reduced significantly in dementia patients compared to the controls. In the AD/SDAT patients
cholinesterase
and
somatostatin
-like immunoreactivity levels seemed to be correlated with the severity of dementia. These findings agree with observations of reduced cortical
acetylcholinesterase
activities and
somatostatin
values in dementia of the Alzheimer type.
...
PMID:Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type. 614 29
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>